These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30476356)

  • 1. How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies.
    Neale J; Brown C; Campbell ANC; Jones JD; Metz VE; Strang J; Comer SD
    Addiction; 2019 Apr; 114(4):708-718. PubMed ID: 30476356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.
    Parkin S; Neale J; Brown C; Jones JD; Brandt L; Castillo F; Campbell ANC; Strang J; Comer SD
    Int J Drug Policy; 2021 Jan; 87():102968. PubMed ID: 33096365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is a randomised controlled trial of take home naloxone distributed in emergency settings likely to be feasible and acceptable? Findings from a UK qualitative study exploring perspectives of people who use opioids and emergency services staff.
    Sampson FC; Hughes J; Long J; Buykx P; Goodacre SW; Snooks H; Edwards A; Evans B; Jones J; Moore C; Johnston S
    BMC Emerg Med; 2024 Apr; 24(1):75. PubMed ID: 38679713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
    Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
    Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis.
    Neale J; Kalk NJ; Parkin S; Brown C; Brandt L; Campbell ANC; Castillo F; Jones JD; Strang J; Comer SD
    J Subst Abuse Treat; 2020 Oct; 117():108099. PubMed ID: 32811629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
    Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
    Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training law enforcement to respond to opioid overdose with naloxone: Impact on knowledge, attitudes, and interactions with community members.
    Wagner KD; Bovet LJ; Haynes B; Joshua A; Davidson PJ
    Drug Alcohol Depend; 2016 Aug; 165():22-8. PubMed ID: 27262898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program.
    Katzman JG; Takeda MY; Greenberg N; Moya Balasch M; Alchbli A; Katzman WG; Salvador JG; Bhatt SR
    JAMA Netw Open; 2020 Feb; 3(2):e200117. PubMed ID: 32101312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
    O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
    BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City.
    Bennett AS; Scheidell J; Bowles JM; Khan M; Roth A; Hoff L; Marini C; Elliott L
    Harm Reduct J; 2022 Mar; 19(1):20. PubMed ID: 35246165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm - An analysis informed by drug, set and setting.
    Holmén E; Hammarberg A; Kåberg M; Storbjörk J
    Int J Drug Policy; 2023 May; 115():104021. PubMed ID: 37011507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Witnessed overdoses and naloxone use among visitors to Rikers Island jails trained in overdose rescue.
    Huxley-Reicher Z; Maldjian L; Winkelstein E; Siegler A; Paone D; Tuazon E; Nolan ML; Jordan A; MacDonald R; Kunins HV
    Addict Behav; 2018 Nov; 86():73-78. PubMed ID: 29175025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone--does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose.
    Neale J; Strang J
    Addiction; 2015 Oct; 110(10):1644-52. PubMed ID: 26119038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of overdose prevention trainings in New York City: Knowledge and self-efficacy among participants 12 months after training.
    Maldjian L; Siegler A; Kunins HV
    Subst Abus; 2016; 37(3):459-465. PubMed ID: 26731134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs.
    Dietze PM; Draper B; Olsen A; Chronister KJ; van Beek I; Lintzeris N; Dwyer R; Nelson M; Lenton S
    Drug Alcohol Rev; 2018 May; 37(4):472-479. PubMed ID: 29473245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people's perceptions of the BC take home naloxone program.
    Mitchell K; Durante SE; Pellatt K; Richardson CG; Mathias S; Buxton JA
    Harm Reduct J; 2017 Jun; 14(1):34. PubMed ID: 28592287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
    Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
    J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods.
    Ashrafioun L; Gamble S; Herrmann M; Baciewicz G
    Subst Abus; 2016; 37(1):76-81. PubMed ID: 26514071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.